{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:53:30Z","timestamp":1787025210923,"version":"build-2736575974"},"reference-count":36,"publisher":"American Diabetes Association","issue":"4","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To determine the prevalence of disturbances in glucose metabolism in patients with acute stroke.<\/jats:p>\n                  <jats:p>RESEARCH DESIGN AND METHODS\u2014Consecutively admitted acute stroke patients (n = 286) were screened for glucose tolerance according to the standardized World Health Organization protocol in the 1st and 2nd week after the stroke event. In addition, we repeatedly measured fasting capillary blood glucose during the first 10 days.<\/jats:p>\n                  <jats:p>RESULTS\u2014Measurements were not performed or cancelled if patients were not fully conscious or had severe dysphagia or early complications that made transfers to other hospitals necessary (n = 48). Of the remaining 238 patients, 20.2% had previously known diabetes; 16.4% were classified as having newly diagnosed diabetes, 23.1% as having impaired glucose tolerance (IGT), and 0.8% as having impaired fasting glucose; and only 19.7% showed normal glucose levels. Another 47 patients (19.7%) had hyperglycemic values only in the 1st week (transient hyperglycemia) or could not be fully classified due to missing data in the oral glucose tolerance test. Patients with diabetes compared with nondiabetic subjects had more severe strokes (National Institutes of Health Stroke Scale [NIHSS] on admission: 7.2 \u00b1 6.6 vs. 4.6 \u00b1 3.1, 4.2 \u00b1 4.4, and 3.7 \u00b1 3.6 for IGT, transient hyperglycemia, and normoglycemia, respectively; P &amp;lt; 0.001), a worse outcome (modified Rankin scale 0\u20131 at discharge: 40.2 vs. 54.4, 63.8, and 72.3% for IGT, transient hyperglycemia, and normoglycemia, respectively; P &amp;lt; 0.001), and a higher rate of infectious complications (35.6 vs. 12.3, 21.2, and 4.2% for IGT, transient hyperglycemia, and normoglycemia, respectively; P &amp;lt; 0.001). In the multivariate analysis, NIHSS on admission, female sex, and the occurrence of urinary tract infection were independently associated with newly diagnosed diabetes.<\/jats:p>\n                  <jats:p>CONCLUSIONS\u2014The majority of acute stroke patients have disorders of glucose metabolism, and in most cases this fact has been unrecognized. Diabetes worsens the outcome of acute stroke. Therefore, in the post\u2013acute phase, an oral glucose tolerance test should be recommended in all stroke patients with no prior history of diabetes.<\/jats:p>","DOI":"10.2337\/diacare.29.04.06.dc05-1818","type":"journal-article","created":{"date-parts":[[2006,5,10]],"date-time":"2006-05-10T18:42:37Z","timestamp":1147286557000},"page":"792-797","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":165,"title":["Disorders of Glucose Metabolism in Acute Stroke Patients"],"prefix":"10.2337","volume":"29","author":[{"given":"Karl","family":"Matz","sequence":"first","affiliation":[{"name":"Department of Neurology, Donauklinikum and Neurosciences Centre, Donau-Universita\u0308t, Maria Gugging, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Keresztes","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donauklinikum and Neurosciences Centre, Donau-Universita\u0308t, Maria Gugging, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tatschl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donauklinikum and Neurosciences Centre, Donau-Universita\u0308t, Maria Gugging, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Nowotny","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donauklinikum and Neurosciences Centre, Donau-Universita\u0308t, Maria Gugging, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dachenhausen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donauklinikum and Neurosciences Centre, Donau-Universita\u0308t, Maria Gugging, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brainin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donauklinikum and Neurosciences Centre, Donau-Universita\u0308t, Maria Gugging, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[{"name":"Department of Public Health, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031303192068100_R1","doi-asserted-by":"crossref","unstructured":"Lam KS, Ma JT, Woo E, Lam C, Yu YL: High prevalence of undiagnosed diabetes among Chinese patients with ischemic stroke. Diabetes Res Clin Pract\u200814: 133\u2013137, 1991","DOI":"10.1016\/0168-8227(91)90119-X"},{"key":"2022031303192068100_R2","doi-asserted-by":"crossref","unstructured":"Gray CS, Scott JF, French JM, Alberti KG, O\u2019Connell JE: Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing\u200833:71\u201377, 2004","DOI":"10.1093\/ageing\/afh026"},{"key":"2022031303192068100_R3","doi-asserted-by":"crossref","unstructured":"Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet\u2008359:2140\u20132144, 2002","DOI":"10.1016\/S0140-6736(02)09089-X"},{"key":"2022031303192068100_R4","doi-asserted-by":"crossref","unstructured":"Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC: Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med\u200824:227\u2013233, 2005","DOI":"10.1001\/archinte.165.2.227"},{"key":"2022031303192068100_R5","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E, Khaw KT: Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol\u2008128:116\u2013123, 1988","DOI":"10.1093\/oxfordjournals.aje.a114934"},{"key":"2022031303192068100_R6","doi-asserted-by":"crossref","unstructured":"Burchfiel CM, Curb JD, Rodriguez BL, Abbott RD, Chiu D, Yano K: Glucose intolerance and 22-year stroke incidence: The Honolulu Heart Program. Stroke\u200825:951\u2013957, 1994","DOI":"10.1161\/01.STR.25.5.951"},{"key":"2022031303192068100_R7","doi-asserted-by":"crossref","unstructured":"Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, Heiss G: Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care\u200822:1077\u20131083, 1999","DOI":"10.2337\/diacare.22.7.1077"},{"key":"2022031303192068100_R8","doi-asserted-by":"crossref","unstructured":"Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation\u2008103:163\u2013182, 2001","DOI":"10.1161\/01.CIR.103.1.163"},{"key":"2022031303192068100_R9","doi-asserted-by":"crossref","unstructured":"Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E: Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke\u200827:210\u2013215, 1996","DOI":"10.1161\/01.STR.27.2.210"},{"key":"2022031303192068100_R10","doi-asserted-by":"crossref","unstructured":"Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM: Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes\u200853:2095\u20132100, 2004","DOI":"10.2337\/diabetes.53.8.2095"},{"key":"2022031303192068100_R11","doi-asserted-by":"crossref","unstructured":"Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care\u200822:233\u2013240, 1999","DOI":"10.2337\/diacare.22.2.233"},{"key":"2022031303192068100_R12","doi-asserted-by":"crossref","unstructured":"Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J: Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry Study. Diabetes Care\u200820:163\u2013169, 1997","DOI":"10.2337\/diacare.20.2.163"},{"key":"2022031303192068100_R13","doi-asserted-by":"crossref","unstructured":"Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care\u200824:447\u2013455, 2001","DOI":"10.2337\/diacare.24.3.447"},{"key":"2022031303192068100_R14","doi-asserted-by":"crossref","unstructured":"Koren-Morag N, Goldbourt U, Tanne D: Relationship between the metabolic syndrome and ischemic stroke or transient ischemic attack. Stroke\u200836:1366\u20131371, 2005","DOI":"10.1161\/01.STR.0000169945.75911.33"},{"key":"2022031303192068100_R15","doi-asserted-by":"crossref","unstructured":"Bravata DM, Wells CK, Kernan WN, Concato J, Brass LM, Gulanski BI: Association between impaired insulin sensitivity and stroke. Neuroepidemiology\u200825:69\u201374, 2005","DOI":"10.1159\/000086286"},{"key":"2022031303192068100_R16","doi-asserted-by":"crossref","unstructured":"Alberti KG: Impaired glucose tolerance: fact or fiction. Diabet Med\u200813(Suppl. 2):S6\u2013S8, 1996","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E"},{"key":"2022031303192068100_R17","doi-asserted-by":"crossref","unstructured":"Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med\u2008344:1343\u20131350, 2001","DOI":"10.1056\/NEJM200105033441801"},{"key":"2022031303192068100_R18","doi-asserted-by":"crossref","unstructured":"Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR: Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology\u200859:67\u201371, 2002","DOI":"10.1212\/WNL.59.1.67"},{"key":"2022031303192068100_R19","doi-asserted-by":"crossref","unstructured":"Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM: Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol\u200852:20\u201328, 2002","DOI":"10.1002\/ana.10241"},{"key":"2022031303192068100_R20","unstructured":"World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Geneva, World Health Org., 1999"},{"key":"2022031303192068100_R21","doi-asserted-by":"crossref","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care\u200825(Suppl. 1):S5\u2013S20, 2002","DOI":"10.2337\/diacare.25.2007.S5"},{"key":"2022031303192068100_R22","doi-asserted-by":"crossref","unstructured":"Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V: Measurements of acute cerebral infarction: a clinical examination scale. Stroke\u200820:864\u2013870, 1989","DOI":"10.1161\/01.STR.20.7.864"},{"key":"2022031303192068100_R23","doi-asserted-by":"crossref","unstructured":"Bonita R, Beaglehole R: Recovery of motor function after stroke. Stroke\u200819:1497\u20131500, 1988","DOI":"10.1161\/01.STR.19.12.1497"},{"key":"2022031303192068100_R24","doi-asserted-by":"crossref","unstructured":"Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke\u200832:2426\u20132432, 2001","DOI":"10.1161\/hs1001.096194"},{"key":"2022031303192068100_R25","doi-asserted-by":"crossref","unstructured":"DECODE Study Group: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia\u200846:608\u2013617, 2003","DOI":"10.1007\/s00125-003-1096-6"},{"key":"2022031303192068100_R26","doi-asserted-by":"crossref","unstructured":"Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J\u200825:1990\u20131997, 2004","DOI":"10.1016\/j.ehj.2004.09.021"},{"key":"2022031303192068100_R27","doi-asserted-by":"crossref","unstructured":"DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med\u2008161:397\u2013405, 2001","DOI":"10.1001\/archinte.161.3.397"},{"key":"2022031303192068100_R28","doi-asserted-by":"crossref","unstructured":"Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM: Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med\u2008162:209\u2013216, 2002","DOI":"10.1001\/archinte.162.2.209"},{"key":"2022031303192068100_R29","doi-asserted-by":"crossref","unstructured":"DECODE Study Group: Consequences of the new diagnostic criteria for diabetes in older men and women. Diabetes Care\u200822:1667\u20131671, 1999","DOI":"10.2337\/diacare.22.10.1667"},{"key":"2022031303192068100_R30","doi-asserted-by":"crossref","unstructured":"Qiao Q, Tuomilehto J, Borch-Johnsen K: Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Diabetologia\u200846:M17\u2013M21, 2003","DOI":"10.1007\/s00125-002-0932-4"},{"key":"2022031303192068100_R31","doi-asserted-by":"crossref","unstructured":"Woo J, Lam CW, Kay R, Wong AH, Teoh R, Nicholls MG: The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol\u2008Nov\u200847:1174\u20131177, 1990","DOI":"10.1001\/archneur.1990.00530110028011"},{"key":"2022031303192068100_R32","doi-asserted-by":"crossref","unstructured":"Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G: Stroke patterns, etiology and prognosis in patients with diabetes mellitus. Neurology\u200862:1558\u20131562, 2004","DOI":"10.1212\/01.WNL.0000123252.55688.05"},{"key":"2022031303192068100_R33","doi-asserted-by":"crossref","unstructured":"Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE, NINDS rt-PA Stroke Study Group: Admission glucose levels and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology\u200859:669\u2013674, 2002","DOI":"10.1212\/WNL.59.5.669"},{"key":"2022031303192068100_R34","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS): Group intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet\u2008352:837\u2013853, 1998","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2022031303192068100_R35","doi-asserted-by":"crossref","unstructured":"Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension: Systolic Hypertension in Europe Trial Investigators. N Engl J Med\u2008340:677\u2013684, 1999","DOI":"10.1056\/NEJM199903043400902"},{"key":"2022031303192068100_R36","doi-asserted-by":"crossref","unstructured":"Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle modification or metformin. N Engl J Med\u2008346:393\u2013403, 2002","DOI":"10.1056\/NEJMoa012512"}],"updated-by":[{"DOI":"10.2337\/dc06-er07","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000}}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/4\/792\/650481\/zdc00406000792.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/29\/4\/792\/650481\/zdc00406000792.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:46:16Z","timestamp":1647143176000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/29\/4\/792\/39322\/Disorders-of-Glucose-Metabolism-in-Acute-Stroke"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.29.04.06.dc05-1818","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,1]]}}}